Here's a quote from today's press release,
"
"Thursday January 22, 8:19 am Eastern Time
Company Press Release
SOURCE: MedImmune, Inc.
MedImmune Closes $66.3 Million Private Placement
GAITHERSBURG, Md., Jan. 22 /PRNewswire/ -- MedImmune, Inc. (Nasdaq: MEDI - news) today announced that it has
closed the private placement of 1,700,000 new shares of common stock to institutional investors BB Biotech, Investor AB
and INVESCO Trust Company resulting in net proceeds to MedImmune of $66.3 million. The private placement was
self-managed by MedImmune and was first announced on January 13, 1998. MedImmune now has 26.2 million shares
outstanding. "
Jim |
